Cel-Sci
CVM
#9766
Rank
โ‚ฌ44.61 M
Marketcap
5,58ย โ‚ฌ
Share price
-1.95%
Change (1 day)
-69.38%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -โ‚ฌ22.54 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ22.71 Million, an increase over its 2023 earnings that were of -โ‚ฌ25.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ22.54 Million-0.76%
2024 -โ‚ฌ22.71 Million-12.41%
2023 -โ‚ฌ25.93 Million-12.87%
2022 -โ‚ฌ29.76 Million-3.42%
2021 -โ‚ฌ30.81 Million13.44%
2020 -โ‚ฌ27.16 Million11.28%
2019 -โ‚ฌ24.41 Million179.81%
2018 -โ‚ฌ8.73 Million-48.72%
2017 -โ‚ฌ17.01 Million-16.23%
2016 -โ‚ฌ20.31 Million-23.63%
2015 -โ‚ฌ26.59 Million-5.47%
2014 -โ‚ฌ28.13 Million198.49%
2013 -โ‚ฌ9.43 Million
2010 -โ‚ฌ11 Million
2004 -โ‚ฌ3.72 Million12.38%
2003 -โ‚ฌ3.31 Million-16.59%
2002 -โ‚ฌ3.97 Million-59.28%
2001 -โ‚ฌ9.74 Million23.17%
2000 -โ‚ฌ7.91 Million20.12%
1999 -โ‚ฌ6.59 Million13.24%
1998 -โ‚ฌ5.82 Million-20%
1997 -โ‚ฌ7.27 Million46.55%
1996 -โ‚ฌ4.96 Million34.88%
1995 -โ‚ฌ3.68 Million2.38%
1994 -โ‚ฌ3.59 Million68%
1993 -โ‚ฌ2.14 Million78.57%
1992 -โ‚ฌ1.2 Million180%
1991 -โ‚ฌ0.43 Million25%
1990 -โ‚ฌ0.35 Million-0%
1989 -โ‚ฌ0.35 Million-71.43%
1988 -โ‚ฌ1.2 Million-0%
1987 -โ‚ฌ1.2 Million-46.15%
1986 -โ‚ฌ2.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-โ‚ฌ27.83 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.66 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.04 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚ฌ0.12 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.51 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ27.68 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.12 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA